Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 24/10/19961 min de leitura
Guidant Corp.; Premarket Approval of SELUTERegister Steroid Eluting Endocardial Lead Models 4185 and 4285
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing its approval of the application by Guidant Corp., St. Paul, MN, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of SELUTE Steroid Eluting Endocardial Lead Models 4185 and 4285. FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of May 8, 1996, of the approval of the application.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →